Atlas Trials

Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration

Clinical trial NCT04241536 · COMPLETED

Trial details

NCT number
NCT04241536
Sponsor
Association for Innovation and Biomedical Research on Light and Image
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Age-related Macular Degeneration
Start date
2021-06-01
Primary completion
2022-11-29
Enrollment
295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.